Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis.

[1]  I. Orme,et al.  Memory T cell subsets in tuberculosis: what should we be targeting? , 2014, Tuberculosis.

[2]  P. Andersen,et al.  Tuberculosis vaccines--rethinking the current paradigm. , 2014, Trends in immunology.

[3]  Alessandro Sette,et al.  Antigens for CD4 and CD8 T cells in tuberculosis. , 2014, Cold Spring Harbor perspectives in medicine.

[4]  J. Ernst,et al.  Cell-to-cell transfer of M. tuberculosis antigens optimizes CD4 T cell priming. , 2014, Cell host & microbe.

[5]  V. Sosunov,et al.  Gr-1dimCD11b+ Immature Myeloid-Derived Suppressor Cells but Not Neutrophils Are Markers of Lethal Tuberculosis Infection in Mice , 2014, The Journal of Immunology.

[6]  T. Ottenhoff,et al.  Innovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide Analyses , 2014, Front. Immunol..

[7]  S. Kaufmann.  Tuberculosis vaccine development at a divide , 2014, Current opinion in pulmonary medicine.

[8]  G. De Libero,et al.  The T-Cell Response to Lipid Antigens of Mycobacterium tuberculosis , 2014, Front. Immunol..

[9]  B. Eisele,et al.  The BCG replacement vaccine VPM1002: from drawing board to clinical trial , 2014, Expert review of vaccines.

[10]  E. Agger,et al.  Protective CD4 T Cells Targeting Cryptic Epitopes of Mycobacterium tuberculosis Resist Infection-Driven Terminal Differentiation , 2014, The Journal of Immunology.

[11]  D. Barber,et al.  Cutting Edge: Control of Mycobacterium tuberculosis Infection by a Subset of Lung Parenchyma–Homing CD4 T Cells , 2014, The Journal of Immunology.

[12]  A. Rothchild,et al.  In search of a new paradigm for protective immunity to TB , 2014, Nature Reviews Microbiology.

[13]  R. Copin,et al.  Sequence Diversity in the pe_pgrs Genes of Mycobacterium tuberculosis Is Independent of Human T Cell Recognition , 2014, mBio.

[14]  D. Tobin,et al.  Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids , 2013, Nature.

[15]  JoAnne L. Flynn,et al.  Sterilization of granulomas is common in both active and latent tuberculosis despite extensive within-host variability in bacterial killing , 2014 .

[16]  B. Bloom,et al.  TB or Not TB: That Is No Longer the Question , 2013, Science Translational Medicine.

[17]  S. Sridhar,et al.  Harnessing local and systemic immunity for vaccines against tuberculosis , 2013, Mucosal Immunology.

[18]  H. A. Schreiber,et al.  Essential yet limited role for CCR2+ inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming , 2013, eLife.

[19]  N. Mulder,et al.  Co-infection with Mycobacterium tuberculosis and human immunodeficiency virus: an overview and motivation for systems approaches. , 2013, Pathogens and disease.

[20]  I. Orme,et al.  Gr1intCD11b+ Myeloid-Derived Suppressor Cells in Mycobacterium tuberculosis Infection , 2013, PloS one.

[21]  Sang-Nae Cho,et al.  Differentiation of Antigen-Specific T Cells with Limited Functional Capacity during Mycobacterium tuberculosis Infection , 2013, Infection and Immunity.

[22]  B. Gicquel,et al.  Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials. , 2013, Vaccine.

[23]  P. V. van Helden,et al.  Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function. , 2013, American journal of respiratory and critical care medicine.

[24]  J. Ernst,et al.  Cutting Edge: Direct Recognition of Infected Cells by CD4 T Cells Is Required for Control of Intracellular Mycobacterium tuberculosis In Vivo , 2013, The Journal of Immunology.

[25]  S. Way,et al.  Pathogen-specific Treg cells expand early during mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12. , 2013, Immunity.

[26]  D. Sherman,et al.  Human Mycobacterium tuberculosis CD8 T Cell Antigens/Epitopes Identified by a Proteomic Peptide Library , 2013, PloS one.

[27]  P. Andersen,et al.  Control of Chronic Mycobacterium tuberculosis Infection by CD4 KLRG1− IL-2–Secreting Central Memory Cells , 2013, The Journal of Immunology.

[28]  Delia Goletti,et al.  Mycobacterium tuberculosis‐specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease , 2013, European journal of immunology.

[29]  H. McShane,et al.  Vaccination against tuberculosis: how can we better BCG? , 2013, Microbial pathogenesis.

[30]  L. Ramakrishnan,et al.  TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species , 2013, Cell.

[31]  M. Brennan,et al.  Preventive vaccines for tuberculosis. , 2013, Vaccine.

[32]  S. Vigano,et al.  Lack of Mycobacterium tuberculosis–specific interleukin‐17A–producing CD4+ T cells in active disease , 2013, European journal of immunology.

[33]  M. Jenkins,et al.  CD4+ T Cell Persistence and Function after Infection Are Maintained by Low-Level Peptide:MHC Class II Presentation , 2013, The Journal of Immunology.

[34]  A. Casadevall,et al.  Antibody-mediated immunity against tuberculosis: implications for vaccine development. , 2013, Cell host & microbe.

[35]  T. Mihăescu,et al.  History of BCG Vaccine. , 2013, Maedica.

[36]  S. Lockhart,et al.  Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial , 2013, The Lancet.

[37]  Bjoern Peters,et al.  Memory T Cells in Latent Mycobacterium tuberculosis Infection Are Directed against Three Antigenic Islands and Largely Contained in a CXCR3+CCR6+ Th1 Subset , 2013, PLoS pathogens.

[38]  R. Appelberg,et al.  Nitric oxide inhibits the accumulation of CD4+CD44hiTbet+CD69lo T cells in mycobacterial infection , 2012, European journal of immunology.

[39]  Lindsay R. Ancelet,et al.  Oral Vaccination with Lipid-Formulated BCG Induces a Long-lived, Multifunctional CD4+ T Cell Memory Immune Response , 2012, PloS one.

[40]  V. Fofanov,et al.  Beijing Sublineages of Mycobacterium tuberculosis Differ in Pathogenicity in the Guinea Pig , 2012, Clinical and Vaccine Immunology.

[41]  L. Picker,et al.  Hidden Memories: Frontline Memory T Cells and Early Pathogen Interception , 2012, The Journal of Immunology.

[42]  S. Spector,et al.  Vitamin D Inhibits Human Immunodeficiency Virus Type 1 and Mycobacterium tuberculosis Infection in Macrophages through the Induction of Autophagy , 2012, PLoS pathogens.

[43]  S. Kaufmann,et al.  Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go? , 2012, PLoS pathogens.

[44]  L. Ramakrishnan.  Revisiting the role of the granuloma in tuberculosis , 2012, Nature Reviews Immunology.

[45]  M. Jeyanathan,et al.  Mechanisms of delayed anti-tuberculosis protection in the lung of parenteral BCG-vaccinated hosts: A critical role of airway luminal T cells , 2012, Mucosal Immunology.

[46]  John P. Ray,et al.  Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections , 2012, Cell.

[47]  J. Ernst,et al.  Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells. , 2012, Cell host & microbe.

[48]  T. Ottenhoff,et al.  Simultaneous Immunization against Tuberculosis , 2011, PloS one.

[49]  E. Chan,et al.  Increased Foxp3 expression in guinea pigs infected with W-Beijing strains of M. tuberculosis. , 2011, Tuberculosis.

[50]  I. Orme,et al.  Mycobacterium bovis BCG-Mediated Protection against W-Beijing Strains of Mycobacterium tuberculosis Is Diminished Concomitant with the Emergence of Regulatory T Cells , 2011, Clinical and Vaccine Immunology.

[51]  H. Whittle,et al.  Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? , 2011, The Journal of infectious diseases.

[52]  J. Ernst,et al.  Lung Neutrophils Facilitate Activation of Naive Antigen-Specific CD4+ T Cells during Mycobacterium tuberculosis Infection , 2011, The Journal of Immunology.

[53]  Bali Pulendran,et al.  Immunological mechanisms of vaccination , 2011, Nature Immunology.

[54]  E. Wherry.  T cell exhaustion , 2011, Nature Immunology.

[55]  M. Jenkins,et al.  Origins of CD4+ effector and central memory T cells , 2011, Nature Immunology.

[56]  J. Ernst,et al.  Initiation and regulation of T-cell responses in tuberculosis , 2011, Mucosal Immunology.

[57]  J. Ernst,et al.  Suboptimal Activation of Antigen-Specific CD4+ Effector Cells Enables Persistence of M. tuberculosis In Vivo , 2011, PLoS pathogens.

[58]  M. Glickman,et al.  A Gamma Interferon Independent Mechanism of CD4 T Cell Mediated Control of M. tuberculosis Infection in vivo , 2011, PLoS pathogens.

[59]  M. Bevan.  Memory T cells as an occupying force , 2011, European journal of immunology.

[60]  C. K. Kwan,et al.  HIV and Tuberculosis: a Deadly Human Syndemic , 2011, Clinical Microbiology Reviews.

[61]  A. O’Garra,et al.  The role of IL-10 in immune regulation during M. tuberculosis infection , 2011, Mucosal Immunology.

[62]  Matthew S. Lewis,et al.  Profound early control of highly pathogenic SIV by an effector-memory T cell vaccine , 2011, Nature.

[63]  A. Dyrhol-Riise,et al.  T Regulatory Cells and Immune Activation in Mycobacterium tuberculosis Infection and the Effect of Preventive Therapy , 2011, Scandinavian journal of immunology.

[64]  G. Pantaleo,et al.  Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease , 2011, Nature Network Boston.

[65]  R. Hunter,et al.  Immunopathology of Postprimary Tuberculosis: Increased T-Regulatory Cells and DEC-205-Positive Foamy Macrophages in Cavitary Lesions , 2010, Clinical & developmental immunology.

[66]  Sarman Singh,et al.  Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells , 2010, Proceedings of the National Academy of Sciences.

[67]  Stefan H E Kaufmann,et al.  Future vaccination strategies against tuberculosis: thinking outside the box. , 2010, Immunity.

[68]  R. Ahmed,et al.  From vaccines to memory and back. , 2010, Immunity.

[69]  V. Kuchroo,et al.  Tim3 binding to galectin-9 stimulates antimicrobial immunity , 2010, The Journal of experimental medicine.

[70]  M. Jenkins,et al.  Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection , 2010, Proceedings of the National Academy of Sciences.

[71]  S. Behar,et al.  Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? , 2010, Nature Reviews Microbiology.

[72]  K. Takatsu,et al.  Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis , 2010, The Journal of experimental medicine.

[73]  M. Rojas,et al.  Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. , 2010, Tuberculosis.

[74]  M. Jeyanathan,et al.  Airway luminal T cells: a newcomer on the stage of TB vaccination strategies. , 2010, Trends in immunology.

[75]  M. Bevan,et al.  From the thymus to longevity in the periphery. , 2010, Current opinion in immunology.

[76]  J. Galagan,et al.  Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved , 2010, Nature Genetics.

[77]  M. Jeyanathan,et al.  Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment. , 2010, American journal of respiratory and critical care medicine.

[78]  H. Whittle,et al.  Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau , 2010, BMJ : British Medical Journal.

[79]  David M. Tobin,et al.  The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans , 2010, Cell.

[80]  E. Tchilian,et al.  Immunization of Mice with a Recombinant Adenovirus Vaccine Inhibits the Early Growth of Mycobacterium tuberculosis After Infection , 2009, PloS one.

[81]  P. Saha,et al.  FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. , 2009, American journal of respiratory and critical care medicine.

[82]  B. Haynes,et al.  A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis , 2009, PLoS pathogens.

[83]  A. Cooper,et al.  Cell-mediated immune responses in tuberculosis. , 2009, Annual review of immunology.

[84]  J. Kohlmeier,et al.  Migration, maintenance and recall of memory T cells in peripheral tissues , 2009, Nature Reviews Immunology.

[85]  M. Glickman,et al.  Delayed protection by ESAT-6–specific effector CD4+ T cells after airborne M. tuberculosis infection , 2008, The Journal of experimental medicine.

[86]  Alan D. Roberts,et al.  ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes , 2008, Proceedings of the National Academy of Sciences.

[87]  J. Altman,et al.  Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. , 2008, Immunity.

[88]  S. Khader,et al.  IL-23 and IL-17 in tuberculosis. , 2008, Cytokine.

[89]  J. Ernst,et al.  Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs , 2008, The Journal of experimental medicine.

[90]  J. Casanova,et al.  Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis. , 2007, Annual review of genomics and human genetics.

[91]  A. Rudensky,et al.  Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis , 2007, The Journal of experimental medicine.

[92]  J. Ernst,et al.  Mycobacterium tuberculosis Infects Dendritic Cells with High Frequency and Impairs Their Function In Vivo1 , 2007, The Journal of Immunology.

[93]  S. Kaufmann,et al.  Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis , 2007, Proceedings of the National Academy of Sciences.

[94]  I. Orme,et al.  The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation1 , 2007, The Journal of Immunology.

[95]  G. Rook.  Th2 cytokines in susceptibility to tuberculosis. , 2007, Current molecular medicine.

[96]  Helen A Fletcher,et al.  Correlates of immune protection from tuberculosis. , 2007, Current molecular medicine.

[97]  Alimuddin Zumla,et al.  FOXP3 gene expression in a tuberculosis case contact study , 2007, Clinical and experimental immunology.

[98]  R. Locksley,et al.  IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.

[99]  Xinchun Chen,et al.  CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. , 2007, Clinical immunology.

[100]  S. Kaufmann,et al.  Cutting Edge: Regulatory T Cells Prevent Efficient Clearance of Mycobacterium tuberculosis , 2007, The Journal of Immunology.

[101]  Yu-Jin Jung,et al.  Expression levels of Mycobacterium tuberculosis antigen‐encoding genes versus production levels of antigen‐specific T cells during stationary level lung infection in mice , 2006, Immunology.

[102]  J. Pieters.  Faculty Opinions recommendation of Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. , 2006 .

[103]  Z. Toossi,et al.  A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis , 2006, Clinical and experimental immunology.

[104]  A. Lalvani,et al.  Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. , 2006, American journal of respiratory and critical care medicine.

[105]  P. Aaby,et al.  Bacillus Calmette-Guérin vaccination and infant mortality , 2006, Expert review of vaccines.

[106]  S. Kaufmann,et al.  Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. , 2005, The Journal of clinical investigation.

[107]  P. Andersen,et al.  The success and failure of BCG — implications for a novel tuberculosis vaccine , 2005, Nature Reviews Microbiology.

[108]  A. Sher,et al.  Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. , 2005, The Journal of clinical investigation.

[109]  D. Elías,et al.  PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[110]  T. Braciale,et al.  Activation, Differentiation, and Migration of Naive Virus-Specific CD8+ T Cells during Pulmonary Influenza Virus Infection1 , 2004, The Journal of Immunology.

[111]  A. Myers,et al.  Non-human primates: a model for tuberculosis research. , 2003, Tuberculosis.

[112]  C. Dascher,et al.  Dissemination of Mycobacterium tuberculosis Is Influenced by Host Factors and Precedes the Initiation of T-Cell Immunity , 2002, Infection and Immunity.

[113]  R. Appelberg,et al.  Failure to induce enhanced protection against tuberculosis by increasing T‐cell‐dependent interferon‐γ generation , 2001, Immunology.

[114]  S. Akira,et al.  [Induction of direct antimicrobial activity through mammalian toll-like receptors]. , 2001, Pneumologie.

[115]  A. Hill,et al.  Vaccines against intracellular infections requiring cellular immunity , 2000, Nature.

[116]  R. Belshe,et al.  Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[117]  P D van Helden,et al.  Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. , 1999, The New England journal of medicine.

[118]  A. Krensky,et al.  Granulysin: a lethal weapon of cytolytic T cells. , 1999, Immunology today.

[119]  I. Orme,et al.  Animal Models of Mycobacteria Infection , 1999, Current protocols in immunology.

[120]  Z. Toossi,et al.  The Role of TGFβ in the Pathogenesis of Human Tuberculosis , 1998 .

[121]  A. Wallgren.  The time-table of tuberculosis. , 1948, Tubercle.

[122]  L. Ramakrishnan.  The zebrafish guide to tuberculosis immunity and treatment. , 2013, Cold Spring Harbor symposia on quantitative biology.

[123]  Mark M. Davis,et al.  The interdisciplinary science of T-cell recognition. , 2013, Advances in immunology.

[124]  K. Urdahl,et al.  Foxp3(+) regulatory T cells in tuberculosis. , 2013, Advances in experimental medicine and biology.

[125]  W. Mitzner,et al.  Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease , 2009, Nature Medicine.

[126]  S. Behar,et al.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity. , 2006, Critical reviews in immunology.

[127]  C. Bonorino,et al.  Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[128]  A. Poulsen.  Some clinical features of tuberculosis. 1. Incubation period. , 1950, Acta tuberculosea Scandinavica.